Xiong Xiao-Bing, Mahmud Abdullah, Uludağ Hasan, Lavasanifar Afsaneh
Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2N8, Canada.
Biomacromolecules. 2007 Mar;8(3):874-84. doi: 10.1021/bm060967g. Epub 2007 Feb 22.
An arginine-glycine-aspartic acid (RGD) containing model peptide was conjugated to the surface of poly(ethylene oxide)-block-poly(epsilon-caprolactone) (PEO-b-PCL) micelles as a ligand that can recognize adhesion molecules overexpressed on the surface of metastatic cancer cells, that is, integrins, and that can enhance the micellar delivery of encapsulated hydrophobic drug into a tumor cell. Toward this goal, PEO-b-PCL copolymers bearing acetal groups on the PEO end were synthesized, characterized, and assembled to polymeric micelles. The acetal group on the surface of the PEO-b-PCL micelles was converted to reactive aldehyde under acidic condition at room temperature. An RGD-containing linear peptide, GRGDS, was conjugated on the surface of the aldehyde-decorated PEO-b-PCL micelles by incubation at room temperature. A hydrophobic fluorescent probe, that is, DiI, was physically loaded in prepared polymeric micelles to imitate hydrophobic drugs loaded in micellar carrier. The cellular uptake of DiI loaded GRGDS-modified micelles by melanoma B16-F10 cells was investigated at 4 and 37 degrees C by fluorescent spectroscopy and confocal microscopy techniques and was compared to the uptake of DiI loaded valine-PEO-b-PCL micelles (as the irrelevant ligand decorated micelles) and free DiI. GRGDS conjugation to polymeric micelles significantly facilitated the cellular uptake of encapsulated hydrophobic DiI most probably by intergrin-mediated cell attachment and endocytosis. The results indicate that acetal-terminated PEO-b-PCL micelles are amenable for introducing targeting moieties on the surface of polymeric micelles and that RGD-peptide conjugated PEO-b-PCL micelles are promising ligand-targeted carriers for enhanced drug delivery to metastatic tumor cells.
一种含精氨酸 - 甘氨酸 - 天冬氨酸(RGD)的模型肽被连接到聚环氧乙烷 - 嵌段 - 聚己内酯(PEO - b - PCL)胶束表面,作为一种配体,它可以识别在转移性癌细胞表面过度表达的黏附分子,即整合素,并能增强包裹在胶束中的疏水性药物向肿瘤细胞的递送。为实现这一目标,合成并表征了在PEO末端带有缩醛基团的PEO - b - PCL共聚物,并将其组装成聚合物胶束。在室温酸性条件下,PEO - b - PCL胶束表面的缩醛基团被转化为活性醛。通过室温孵育,将含RGD的线性肽GRGDS连接到醛修饰的PEO - b - PCL胶束表面。将一种疏水性荧光探针,即碘化丙啶,物理负载到制备的聚合物胶束中,以模拟负载在胶束载体中的疏水性药物。通过荧光光谱和共聚焦显微镜技术,研究了黑色素瘤B16 - F10细胞对负载碘化丙啶的GRGDS修饰胶束在4℃和37℃时的细胞摄取情况,并与负载碘化丙啶的缬氨酸 - PEO - b - PCL胶束(作为无关配体修饰的胶束)和游离碘化丙啶的摄取情况进行了比较。GRGDS与聚合物胶束的连接最有可能通过整合素介导的细胞附着和内吞作用,显著促进了包裹的疏水性碘化丙啶的细胞摄取。结果表明,缩醛封端的PEO - b - PCL胶束适合在聚合物胶束表面引入靶向部分,并且RGD肽连接的PEO - b - PCL胶束是用于增强向转移性肿瘤细胞递送药物的有前景的配体靶向载体。